3X MATCH: 3X MATCH: Today, your gift is TRIPLED to support lifesaving research.

From Research to Results

Our Impact

We invest in research that's changing how we think about cancer. That means more answers, faster breakthroughs, and personalized treatment for every patient. With more than a billion dollars raised to fuel our mission, that's progress. This year, BCRF is the largest private funder of breast cancer research—and the largest private funder of metastatic research—in the U.S.

The Ground We've Gained

Research is revolutionizing our understanding of breast cancer and bringing us closer to a cure. Discover how far science has come since BCRF’s founding in 1993—and how our investigators have been involved in every major breakthrough.

The Ground We\'ve Gained

See the Timeline

We Fund the Best Researchers in the World

At BCRF, we fund the game changers

Meet the Game Changers

Today, we support 255 scientists making a real difference and accelerating progress. Get to know them and learn about their projects.

Our Areas of Focus

Breast cancer is a complex disease with no simple solution, which is why our researchers are tackling it from every angle. Learn about our areas of focus and why each is critical to knowing how to fight cancer from the start, slow its progress and one day stop it from occurring altogether.

Heredity & Ethnicity

Most people who develop breast cancer have no family history of the disease, but we know that’s not always the case. A person’s family history, inheritance, race and ethnicity are all important risk factors that have long been part of our research agenda. Our scientists have been behind major breakthroughs in this area, including discovering the role BRCA1 and BRCA2 play in breast cancer and uncovering the genetic link to more aggressive forms of the disease in women of African descent.

The more progress our researchers make, the better doctors are able to predict who is at risk and what can be done to prevent cancer’s onset.

Read More

Heredity & Ethnicity Researchers

Mylin A. Torres, MD

Mylin Torres, MD is Professor of Radiation Oncology at Emory University School of Medicine where she leads the breast radiation oncology program and serves as...

BCRF Investigator Since 2022

At BCRF, we fund the game changers

Collaborative Initiatives

Impactful breast cancer research isn’t siloed. BCRF helps power several large, multi-year research efforts across institutions and industries.

Be the end of cancer

When you give to BCRF, you're funding critical hours in the lab. More time for research means longer, healthier lives for the ones we love.

Kimberly (right), Diagnosed in 2008
Kimberly (right), Diagnosed in 2008